Risk Intelligence
Regulatory cap on commissions
View Risks →PB Fintech delivered a strong Q4 FY26 with insurance premium growth accelerating to 46% YoY (full year 42%), led by protection premium up 57% and health insurance growing 68%.
✓ Verified against BSE filing
PB Fintech delivered a strong Q4 FY26 with insurance premium growth accelerating to 46% YoY (full year 42%), led by protection premium up 57% and health insurance growing 68%. Operating revenue reached ₹6,794 crore for the year, with PAT at ₹670 crore (2.2% of premium). Renewal revenue ARR surged 63% to ₹1,126 crore, underscoring the compounding value of the existing book. Management reiterated a 30%+ growth trajectory, noting they consistently beat this guidance. Key drivers include superior product segmentation, claims experience, and AI-driven productivity gains. Pesa Bazar turned EBITDA positive this quarter, with expectations of meaningful profitability next year. Risks include potential regulatory changes on commission structures, though management expressed confidence in their ability to adapt given their low-cost, high-persistency book. The company remains focused on growth and quality over near-term profit maximization.
Regulatory cap on commissions
View Risks →New insurance premium net of savings grew 59% YoY in Q4, accelerating from prior quarters.
Annualized renewal revenue run-rate reached ₹1,126 crore, up from ₹689 crore a year ago.
Health insurance premium grew 68% YoY for the full year, outpacing other segments.
PB Partners network now includes 450,000 advisors, covering 99% of Indian pin codes.
Management reiterated their long-standing guidance of 30%+ growth, noting they have consistently beaten it.
Media reports suggest potential commission caps in health insurance.
View Risks →